연구성과로 돌아가기
2024 연구성과별 연구자 정보 (1487 / 2344)
※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Document Title | Author Full Name | Author Short Name | Index | Corresponding | Address | ResearcherID | ResearcherID Author Name | ORCID | ORCID Author Name | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
| Multinational randomized trial to investigate the efficacy of tenofovir alafenamide in reducing adverse clinical events in chronic hepatitis B patients who are beyond treatment indications by current guidelines (ATTENTION trial): first interim analysis | Lee, Jeong-Hoon | Lee, JH | 7 | Seoul Natl Univ Hosp, Seoul, South Korea | limys@amc.seoul.kr; | |||||
| Multinational randomized trial to investigate the efficacy of tenofovir alafenamide in reducing adverse clinical events in chronic hepatitis B patients who are beyond treatment indications by current guidelines (ATTENTION trial): first interim analysis | Lee, Yun Bin | Lee, YB | 8 | Seoul Natl Univ Hosp, Seoul, South Korea | limys@amc.seoul.kr; | |||||
| Multinational randomized trial to investigate the efficacy of tenofovir alafenamide in reducing adverse clinical events in chronic hepatitis B patients who are beyond treatment indications by current guidelines (ATTENTION trial): first interim analysis | Park, Neung Hwa | Park, NH | 9 | Ulsan Univ Hosp, Ulsan, South Korea | limys@amc.seoul.kr; | |||||
| Multinational randomized trial to investigate the efficacy of tenofovir alafenamide in reducing adverse clinical events in chronic hepatitis B patients who are beyond treatment indications by current guidelines (ATTENTION trial): first interim analysis | Kwon, So Young | Kwon, SY | 10 | Konkuk Univ, Med Ctr, Seoul, South Korea | limys@amc.seoul.kr; | |||||
| Multinational randomized trial to investigate the efficacy of tenofovir alafenamide in reducing adverse clinical events in chronic hepatitis B patients who are beyond treatment indications by current guidelines (ATTENTION trial): first interim analysis | Jang, Eun Sun | Jang, ES | 11 | Seoul Natl Univ, Bundang Hosp, Seongnam, South Korea | limys@amc.seoul.kr; | |||||
| Multinational randomized trial to investigate the efficacy of tenofovir alafenamide in reducing adverse clinical events in chronic hepatitis B patients who are beyond treatment indications by current guidelines (ATTENTION trial): first interim analysis | Park, Soo Young | Park, SY | 12 | Kyungpook Natl Univ Hosp, Daegu, South Korea | limys@amc.seoul.kr; | |||||
| Multinational randomized trial to investigate the efficacy of tenofovir alafenamide in reducing adverse clinical events in chronic hepatitis B patients who are beyond treatment indications by current guidelines (ATTENTION trial): first interim analysis | Kim, Ji Hoon | Kim, JH | 13 | Korea Univ, Guro Hosp, Seoul, South Korea | limys@amc.seoul.kr; | |||||
| Multinational randomized trial to investigate the efficacy of tenofovir alafenamide in reducing adverse clinical events in chronic hepatitis B patients who are beyond treatment indications by current guidelines (ATTENTION trial): first interim analysis | Yu, Ming-Lung | Yu, ML | 14 | Natl Sun Yat Sen Univ, Kaohsiung, Taiwan | C-9540-2009 | Yu, Ming-Lung | limys@amc.seoul.kr; | |||
| Multinational randomized trial to investigate the efficacy of tenofovir alafenamide in reducing adverse clinical events in chronic hepatitis B patients who are beyond treatment indications by current guidelines (ATTENTION trial): first interim analysis | Chen, Chien-Hung | Chen, CH | 15 | Kaohsiung Chang Gung Mem Hosp, Kaohsiung, Taiwan | limys@amc.seoul.kr; | |||||
| Multinational randomized trial to investigate the efficacy of tenofovir alafenamide in reducing adverse clinical events in chronic hepatitis B patients who are beyond treatment indications by current guidelines (ATTENTION trial): first interim analysis | Hsu, Yao-Chun (Holden) | Hsu, YC | 16 | Fu Jen Catholic Univ, Kaohsiung, Taiwan | limys@amc.seoul.kr; | |||||
| Multinational randomized trial to investigate the efficacy of tenofovir alafenamide in reducing adverse clinical events in chronic hepatitis B patients who are beyond treatment indications by current guidelines (ATTENTION trial): first interim analysis | Bair, Ming-Jong | Bair, MJ | 17 | Mackay Mem Hosp, Taichung, Taiwan | limys@amc.seoul.kr; | |||||
| Multinational randomized trial to investigate the efficacy of tenofovir alafenamide in reducing adverse clinical events in chronic hepatitis B patients who are beyond treatment indications by current guidelines (ATTENTION trial): first interim analysis | Cheng, Pin-Nan | Cheng, PN | 18 | Natl Cheng Kung Univ Hosp, Tainan, Taiwan | limys@amc.seoul.kr; | |||||
| Multinational randomized trial to investigate the efficacy of tenofovir alafenamide in reducing adverse clinical events in chronic hepatitis B patients who are beyond treatment indications by current guidelines (ATTENTION trial): first interim analysis | Tung, Hung-Da | Tung, HD | 19 | Chi Mei Hosp, Tainan, Taiwan | limys@amc.seoul.kr; | |||||
| Multinational randomized trial to investigate the efficacy of tenofovir alafenamide in reducing adverse clinical events in chronic hepatitis B patients who are beyond treatment indications by current guidelines (ATTENTION trial): first interim analysis | Chang, Te-Sheng | Chang, TS | 20 | Chiayi Chang Gung Mem Hosp, Puzy City, Taiwan | limys@amc.seoul.kr; | |||||
| Multinational randomized trial to investigate the efficacy of tenofovir alafenamide in reducing adverse clinical events in chronic hepatitis B patients who are beyond treatment indications by current guidelines (ATTENTION trial): first interim analysis | Chen, Chi-Yi | Chen, CY | 21 | Chia Yi Christian Hosp, Cia Yi, Taiwan | KVZ-1550-2024 | Chen, ChiYi | limys@amc.seoul.kr; |
페이지 이동: